Boston Scientific (BSX) is a publicly traded Healthcare sector company. As of July 2, 2026, BSX trades at $45.71 with a market cap of $63.44B and a P/E ratio of 17.79. BSX moved +6.03% today. Year to date, BSX is -54.53%; over the trailing twelve months it is -58.90%. Its 52-week range spans $42.25 to $109.50. Analyst consensus is strong buy with an average price target of $73.70. Rallies surfaces BSX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Boston Scientific (BSX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BSX moved +6.03% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $45.71 |
| Market Cap | $63.44B |
| P/E Ratio | 17.79 |
| EPS | $2.41 |
| Dividend Yield | 0.00% |
| 52-Week High | $109.50 |
| 52-Week Low | $42.25 |
| Volume | 12.73M |
| Avg Volume | 0 |
| Revenue (TTM) | $20.61B |
| Net Income | $3.56B |
| Gross Margin | 69.17% |
24 analysts cover BSX: 0 strong buy, 21 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $73.70.